Deferiprone protects against doxorubicin-induced myocyte cytotoxicity

This publication has 30 references indexed in Scilit:

• Iron complexes of deferiprone and dietary plant catechols as cytoprotective superoxide radical scavengers
  Biochemical Pharmacology, 2001
• Deferiprone
  Drugs, 1999
• Role of iron in the potentiation of anthracycline cardiotoxicity: Identification of heart cell mitochondria as a major site of iron-anthracycline interaction
  Journal of Laboratory and Clinical Medicine, 1996
• Production of Hydroxyl Radical by Iron(III)-Anthraquinone Complexes through Self-Reduction and through Reductive Activation by the Xanthine Oxidase/Hypoxanthine System
  Archives of Biochemistry and Biophysics, 1995
• A Comparison of the Free Radical Properties of Several Anthracycline Anti-Tumour Drugs and Some of Their Analogues
  Free Radical Research Communications, 1988
• Differences in O2 reduction by the iron complexes of adriamycin and daunomycin: the importance of the sidechain hydroxyl group
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1986
• Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex
  Biochemistry, 1982
• Speciation studies of adriamycin, quelamycin and their metal complexes
  Inorganica Chimica Acta, 1980
• Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1980
• NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.
  Proceedings of the National Academy of Sciences, 1979